Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Pheochromocytoma 1Paraganglioma 1

Interventions

anlotinib 2lutetium Lu 177 dotatate 1Temozolomide 1Catecholamines 190Y-octreotate, DOTA(0)-Tyr(3)-Thr(8)- 13-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Paraganglioma × Catecholamines × Clear all
NCT05451134 2022-07-12

Predictors and Outcomes of Dysglycemia in Pheochromocytoma and Paraganglioma

China National Center for Cardiovascular Diseases

Unknown
300 enrolled
CNSEndocrine

Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡